Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann & Co.
(0.33)
# 4,564
Out of 5,118 analysts
186
Total ratings
32.1%
Success rate
-4.8%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SERV Serve Robotics | Reiterated: Buy | $15 → $14 | $3.22 | +322.36% | 3 | Nov 6, 2026 | |
| ECOR electroCore | Reiterated: Buy | $20 → $19 | $7.25 | +164.83% | 6 | Nov 5, 2026 | |
| DARE Daré Bioscience | Initiated Coverage: Buy | $2 | $0.639 | +212.99% | 1 | Oct 26, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $336 | $180.56 | +86.09% | 1 | Oct 26, 2026 | |
| NMTC NeuroOne Medical Technologies | Reiterated: Buy | $8 → $8.8 | $0.879 | +901.14% | 3 | Aug 14, 2026 | |
| AORT Artivion | Reiterated: Buy | $42 → $39 | $20.21 | +93.96% | 11 | Aug 7, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $31 → $30 | $15.70 | +93.63% | 2 | Jul 30, 2026 | |
| NAGE Niagen Bioscience | Reiterated: Buy | $12 → $11 | $2.07 | +431.40% | 13 | Jul 21, 2026 | |
| NVNO enVVeno Medical | Upgraded: Buy | $30 | $6.73 | +345.77% | 3 | Jul 6, 2026 | |
| LGCY Legacy Education | Reiterated: Buy | $15 → $15 | $8.62 | +78.65% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $26.59 | +20.35% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $14 | $13.72 | +2.04% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $62 | $26.89 | +130.57% | 9 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $9.5 | $11.15 | -14.80% | 8 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $12 | $2.03 | +491.13% | 3 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.6 | $0.9298 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.2 → $14 | $0.0001 | n/a | 6 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $58 | $32.16 | n/a | 13 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.15 | n/a | 11 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $56 | $54.62 | n/a | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.2402 | n/a | 6 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $27 | $7.87 | n/a | 6 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.25 → $30 | $1.11 | n/a | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.2 → $1.6 | $0.98 | n/a | 7 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.58 | n/a | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.4 → $5 | $1.73 | n/a | 5 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1.3 → $3.8 | $0.0001 | n/a | 6 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.03 | n/a | 4 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.50 | n/a | 1 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $85 | $1.93 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.85 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $15.94 | n/a | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $6.75 | $0.4043 | n/a | 2 | Nov 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ILA 5,416 | ILA 3,489 | n/a | 1 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $21 | $2.30 | n/a | 2 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $8.5 | $0.0006 | n/a | 3 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $1.83 | n/a | 2 | Apr 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.25 | $0.0001 | n/a | 1 | Dec 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $22 | $14.27 | n/a | 3 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $0.0002 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.11 | n/a | 2 | Nov 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.35 | $1.56 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 → $100 | $1.69 | n/a | 4 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $48 | $51.50 | n/a | 2 | Apr 27, 2017 |
Serve Robotics
Nov 6, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $3.22
Upside: +322.36%
electroCore
Nov 5, 2026
Reiterated: Buy
Price Target: $20 → $19
Current: $7.25
Upside: +164.83%
Daré Bioscience
Oct 26, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.639
Upside: +212.99%
Nutex Health
Oct 26, 2026
Initiated Coverage: Buy
Price Target: $336
Current: $180.56
Upside: +86.09%
NeuroOne Medical Technologies
Aug 14, 2026
Reiterated: Buy
Price Target: $8 → $8.8
Current: $0.879
Upside: +901.14%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $42 → $39
Current: $20.21
Upside: +93.96%
Beta Bionics
Jul 30, 2026
Reiterated: Buy
Price Target: $31 → $30
Current: $15.70
Upside: +93.63%
Niagen Bioscience
Jul 21, 2026
Reiterated: Buy
Price Target: $12 → $11
Current: $2.07
Upside: +431.40%
enVVeno Medical
Jul 6, 2026
Upgraded: Buy
Price Target: $30
Current: $6.73
Upside: +345.77%
Legacy Education
May 15, 2026
Reiterated: Buy
Price Target: $15 → $15
Current: $8.62
Upside: +78.65%
May 12, 2026
Reiterated: Buy
Price Target: $32
Current: $26.59
Upside: +20.35%
May 12, 2026
Reiterated: Buy
Price Target: $18 → $14
Current: $13.72
Upside: +2.04%
Mar 4, 2026
Reiterated: Buy
Price Target: $66 → $62
Current: $26.89
Upside: +130.57%
Nov 12, 2025
Reiterated: Buy
Price Target: $13 → $9.5
Current: $11.15
Upside: -14.80%
Nov 12, 2025
Reiterated: Buy
Price Target: $10 → $12
Current: $2.03
Upside: +491.13%
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $3.6
Current: $0.9298
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $3.2 → $14
Current: $0.0001
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $72 → $58
Current: $32.16
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Nov 8, 2024
Reiterated: Buy
Price Target: $53 → $56
Current: $54.62
Upside: n/a
Sep 24, 2024
Reiterated: Buy
Price Target: $14
Current: $0.2402
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $52 → $27
Current: $7.87
Upside: n/a
Jun 25, 2024
Reiterated: Buy
Price Target: $3.25 → $30
Current: $1.11
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $3.2 → $1.6
Current: $0.98
Upside: n/a
Nov 8, 2023
Downgraded: Hold
Price Target: n/a
Current: $4.58
Upside: n/a
Nov 7, 2023
Reiterated: Buy
Price Target: $5.4 → $5
Current: $1.73
Upside: n/a
Oct 9, 2023
Downgraded: Hold
Price Target: $1.3 → $3.8
Current: $0.0001
Upside: n/a
Oct 5, 2023
Downgraded: Hold
Price Target: n/a
Current: $3.03
Upside: n/a
Sep 5, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $3.50
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $28 → $85
Current: $1.93
Upside: n/a
Jan 23, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Aug 4, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $1.85
Upside: n/a
May 2, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $15.94
Upside: n/a
Nov 18, 2021
Reiterated: Buy
Price Target: $11 → $6.75
Current: $0.4043
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: ILA 5,416
Current: ILA 3,489
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $11 → $21
Current: $2.30
Upside: n/a
Aug 9, 2021
Reiterated: Buy
Price Target: $12 → $8.5
Current: $0.0006
Upside: n/a
Apr 30, 2021
Reiterated: Buy
Price Target: $25 → $15
Current: $1.83
Upside: n/a
Dec 17, 2020
Initiated Coverage: Buy
Price Target: $8.25
Current: $0.0001
Upside: n/a
Aug 27, 2020
Reiterated: Buy
Price Target: $15 → $22
Current: $14.27
Upside: n/a
Dec 3, 2019
Upgraded: Buy
Price Target: $40
Current: $0.0002
Upside: n/a
Nov 19, 2018
Downgraded: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Nov 27, 2017
Downgraded: Hold
Price Target: $4.35
Current: $1.56
Upside: n/a
May 18, 2017
Upgraded: Buy
Price Target: $50 → $100
Current: $1.69
Upside: n/a
Apr 27, 2017
Downgraded: Hold
Price Target: $55 → $48
Current: $51.50
Upside: n/a